Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Synergy Pharmaceuticals Inc    

SYNERGY PHARMACEUTICALS INC

  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
More Financials
Company
Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin. Uroguanylin physiologically regulates bowel function, fluid balance, and... 
More about the company
Latest news on SYNERGY PHARMACEUTICALS IN
04/29SYNERGY PHARMACEUTICALS, INC. : Bankruptcy or Receivership, Material Modificatio..
AQ
04/02SYNERGY PHARMACEUTICALS, INC. : Bankruptcy or Receivership, Financial Statements..
AQ
03/14SYNERGY PHARMACEUTICALS, INC. : Bankruptcy or Receivership, Financial Statements..
AQ
03/08SYNERGY PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Cont..
AQ
03/06SYNERGY PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Asse..
AQ
03/06SYNERGY PHARMACEUTICALS : Announces Completion of Sale to Bausch Health
PR
03/04SYNERGY PHARMACEUTICALS : Receives Court Approval for the Sale of Its Assets to ..
AQ
03/04SYNERGY PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements a..
AQ
03/01SYNERGY PHARMACEUTICALS : Is Approved to Sell Assets to Bausch Health
DJ
03/01SYNERGY PHARMACEUTICALS : Receives Court Approval for the Sale of Its Assets to ..
PR
More news
Sector news : Bio Therapeutic Drugs
06/19PFIZER : Fitch Puts Pfizer on Watch Negative, Notes Leverage Increase
DJ
06/19GILEAD SCIENCES : Sets Collaboration With Nurix Therapeutics
DJ
06/18WHAT'S NEWS : Business & Finance -- WSJ
DJ
06/18PFIZER : Expands Cancer-Treatment Lineup
DJ
06/17ARRAY BIOPHARMA : Pfizer makes $10.6 billion cancer bet in cash deal for Array B..
RE
More sector news : Bio Therapeutic Drugs
Chart SYNERGY PHARMACEUTICALS INC
Duration : Period :
Synergy Pharmaceuticals Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
EPS Revisions
Managers
NameTitle
Troy Hamilton Chief Executive Officer & Director
Melvin K. Spigelman Chairman
Gary G. Gemignani Secretary, CFO, Principal Accounting Officer & EVP
Patrick H. Griffin Chief Medical Officer & Executive Vice President
John P. Brancaccio Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SYNERGY PHARMACEUTICALS INC-73.66%0
GILEAD SCIENCES9.13%80 909
VERTEX PHARMACEUTICALS7.38%42 680
REGENERON PHARMACEUTICALS-16.78%32 744
GENMAB14.52%10 857
SAREPTA THERAPEUTICS INC23.17%8 523